Skip to content

Effects of Sugammadex on Electroencephalographic Activity and Cognitive Function in Elderly Surgical Patients During Recovery: a single-center, prospective, randomized controlled study

Effects of Sugammadex on Electroencephalographic Activity and Cognitive Function in Elderly Surgical Patients During Recovery: a single-center, prospective, randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106728
Enrollment
Unknown
Registered
2025-07-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Neostigmine group:Neostigmine 0.04 mg/kg + atropine 0.02 mg/kg should be administered for neuromuscular blockade reversal when monitoring shows TOFr > 0.5 and PSI > 60.
Sugammadex Group:Administer Sugammadex Sodium 2 mg/kg + 0.9% normal saline for neuromuscular reversal when monitoring shows TOFr > 0.5 and PSI > 60.

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Consecutively selected elderly patients aged 65-80 (regardless of gender) scheduled to undergo elective total hip/knee arthroplasty under general anesthesia at our center between September 2025 and August 2026.

Exclusion criteria

Exclusion criteria: 1. Inability to provide informed consent or communication difficulties before surgery, with MMSE score 2.0 times the upper limit of normal) diseases; 3. Allergy to any of the anesthetic drugs to be used in the study; 4. History of mental illness or long-term use of psychiatric medications; 5. Contraindications to neostigmine or sugammadex sodium; 6. Patients who refuse to participate.

Design outcomes

Primary

MeasureTime frame
Patient status index;Electromyography indicators;Four strings of stimuli;Electroencephalogram indicators;CAM Scale Score;Serological indicator;

Secondary

MeasureTime frame
Skeletal muscle content;Postoperative complications;

Countries

China

Contacts

Public ContactZhaochu Sun

The First Affiliated Hospital with Nanjing Medical University

suncc520@163.com+86 182 6263 7635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026